We recently described enhanced STAT5 signaling in peripheral blood T cells in AD [34, 35], which might contribute to activation and was shown to promote an endurable effector‐like state in CD8+ T cells [36, 37]. The gene discussed is CD8A; the disease is Alzheimer disease.